Over the past week, the Hang Seng Index edged down 0.14% to 28801.27.

The Hong Kong stock IPO market has recovered from the silence in the past.In the past week, there were 11 IPOs, 5 IPOs and 4 IPOs. Among them, the first share of new-style tea$Nai Xue's tea (02150.HK) $It has been highly sought after, with a total margin of HK $81.794 billion and 160.57 times subscriptions as of press time, and the offering will close next Wednesday.

In addition, three new shares are officially listed on the Hong Kong Stock Exchange.$Angelalign Technology Inc. (06699.HK) $The IPO performed brilliantly, up 122.31% from its share price as of Friday's close.

The IPO aspect of US-listed Chinese stocks$AiHuiShou International Co.Ltd. (RERE.US) $It officially landed on the New York Stock Exchange on the evening of June 18, and closed up 22.93% on the first day, becoming the "first ESG share of Chinese stocks."

China's leading digital freight platform$Full Truck Alliance Co. Ltd. (YMM.US) $In the hot subscription, it is planned to issue 82.5 million shares of ADS in this IPO, with a price range of 17-19 US dollars / ADS. The IPO received the intended investment of existing shareholders Fidelity International and Jingshun Investment, as well as a private placement by Ontario Teachers' Pension Plan (OTPP) and Mubadala, the sovereign wealth fund of the United Arab Emirates.

The first strand of social meta-universe$Soul (SSR.US) $Subscription has also been launched, with a planned issuance of 13.2 million shares of ADS with a range of $13 to $15 per ADS.

There have been 11 IPOs in the past week.

Zhongzhuo Medical ServiceIt is a comprehensive private medical service provider in Hong Kong, operating six medical centres under the brand name "Zhongzhuo Medical". The company ranks sixth among multi-specialist medical centre operators in Hong Kong, with a market share of about 1.3% in terms of revenue generated from the provision of specialist services (including medical and surgical-related specialist services) in 2019.

Zhengda new materialIt is the largest manufacturer of polyetheramine products in China, mainly engaged in the research and development, production and sales of polyetheramine products under the brand of "Zhengda New Materials". According to the output and sales volume of polyetheramine products in China in 2020, the company ranks first.

Newly passed projectIs a digital media company, mainly through the digital media platform to provide integrated advertising solutions to advertisers. In terms of revenue, the company ranked second among Hong Kong online advertising agencies in 2020.

Huzhou gasIt is the largest pipeline natural gas distributor in Huzhou City, a major prefecture-level city in Zhejiang Province, China and the fourth largest pipeline natural gas distributor in Zhejiang Province. The company's main business includes (I) selling gas under franchise agreements; (ii) providing construction and installation services for customers to build and install end-user piping networks and gas facilities; and (iii) others, including the sale of household gas appliances.

Yujia living serviceIs an integrated provider of property management services and business operation services$Yuzhou Group (01628.HK) $Break up. According to the ranking of the top 100 property service enterprises in terms of comprehensive strength, the company ranked 28th in 2021. During the track record period, most of the revenue from the company's property management services came from properties developed by Yuzhou Group, its joint ventures, associated companies and other related parties.

Great Wall propertyIs the largest independent full-industry property management service provider in China. The company provides basic property management services and a number of value-added services to real estate developers, owners and tenants, including sales office management services, space management services, community shopping services, home services and parking lot management services. At the same time, it provides professional services to real estate developers, owners, property management companies, government agencies, transportation hubs and other companies, including construction and installation engineering services, elevator related services and intelligent integrated operation platform services.

And reputation CaymanIs an R & D-driven, clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecular tumor therapies. The company strategically designs and develops a rich pipeline of 14 projects focused on oncology, including four assets in the clinical stage.

Yonghe medical treatmentIt is the largest medical group in China specializing in providing one-stop hair medical services. As of the last practical date, the company operates 51 medical institutions in 50 cities in China, making it the largest and most extensive chain of hair transplant medical institutions in China. Among all the hair medical service providers in China, the company ranks first in terms of various major financial and operational indicators, far surpassing other competitors in the industry.

Yinde HoldingsIs a Hong Kong mechanical and electrical engineering service provider. In terms of market share, the company ranked fifth in the fire services market in Hong Kong in the year ended March 31, 2021. The company specializes in the installation, modification and addition of fire service system as well as maintenance. The company was listed on GEM on February 12, 2018.

Remittance accessIt is a trading and service platform for enterprise customers in the sinking market, providing online and offline supply chain solutions, store SaaS+ services, merchant solutions and other comprehensive services for retail industry chain participants. In terms of the size of transactions facing the sinking market in 2020, the company ranks first in China's trading platform for serving corporate customers in the retail industry.

GC ConstructionIt is a Hong Kong muddy water contractor. The Group's business is carried out by its two major operating subsidiaries, Chen Qiao and Yingwei. The muddy water works carried out mainly include batching, tile laying, brick laying, floor laying and marble works. In terms of revenue, the group ranked first in Hong Kong's subcontracting market for muddy water works in 2020, accounting for 4% of the market share.

A total of five new shares have been heard in the past week.

Gui Chuang Tongqiao Medical treatmentIs the market leader of neurovascular interventional medical devices in China, including acute ischemic stroke (AIS), intracranial aneurysms, carotid artery stenosis, peripheral arterial and venous diseases and dialysis-related diseases. The company's two core products "Jiaolong Intracranial Thrombectomy Stent" and "Ultrafree Drug Eluting PTA Balloon dilatation Catheter" have been commercialized in China.

Propranolol organismIs China's leading innovative invasive cardiovascular device company, currently focusing on the following two treatments: (I) fully degradable stents (BRS) to address the unmet medical needs of Chinese patients in the treatment of coronary or peripheral artery disease, and (ii) renal nerve occlusion (RDN) to address unmet medical needs of patients in the treatment of uncontrolled and refractory hypertension.

Kangsheng GlobalIt is the leading independent clinical special examination service provider in China, with the largest special inspection combination among all independent special inspection suppliers in China, offering more than 3500 test items on the service list, including about 2300 hematological tests. In 2020, the company has the largest market share (42.3%) in China's independent hematology clinical special examination industry by revenue.

Dexin serviceIt is a comprehensive property management service provider in Zhejiang Province, mainly providing property management services, non-owner value-added services and community value-added services. The company maintains close and extensive cooperation with Dexin Group.

$HUTCHMED (China) Limited (00013.HK) $Is a global biomedical company in the commercial stage, focusing on the discovery, development and commercialization of targeted therapy and immunotherapy for cancer and immune diseases. Prior to this, and Huang China Medicine has been in the United States NASDAQ$HUTCHMED (China) Limited (HCM.US) $) and the London Stock Exchange.

HUTCHMED (China) Limited is currently in the process of subscribing and will issue about 104 million shares from June 18 to 23 at an issue price of no more than HK $45 each.

A total of four new shares have been listed in the past week, of which Nai Xue's tea has been highly sought after.

As of 13:00 on June 19th$Nai Xue's tea (02150.HK) $A total margin of HK $81.794 billion was subscribed for 160.57 times, and the offering will close next Wednesday.

It is worth noting that as of 19:00 on the first day of subscription, Nai Xue's tea IPO Fortuo has subscribed for more than HK $17.4 billion, with 40879 customers.

而$Mensong International (02155.HK) $、$Yuexiu Service (06626.HK) $Full subscription has also been recorded.

In the past week, a total of 3 new shares listed on the motherboard, of which the domestic stealth correction leader Angelalign Technology Inc. performance is very eye-catching.

$Angelalign Technology Inc. (06699.HK) $In the dark market of Futu, it opened 92.49% higher, and finally closed up 112.72%, earning HK $39000 per hand. Angelalign Technology Inc. continued its bright trend after the listing, closing at HK $384.6 as of June 18, up 122.31 per cent from its share price.

According to previous public information, the number of applicants for Angelalign Technology Inc. 's public placement was about 792400, with a success rate of 1.5%.In the previous subscription stage, the subscription amount of Angelalign Technology Inc. through Fortune was close to 45.4 billion Hong Kong dollars, with 98140 subscribers, ranking first on the list of new shares subscribed by Fortune, and becoming a new member of Fortune Ta New 10 billion Club.